Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2026-01-05 @ 6:29 PM
Study NCT ID:
NCT04890392
Status:
UNKNOWN
Last Update Posted:
2021-08-12
First Post:
2021-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-27
First Submit QC Date:
None
Study First Post Date:
2021-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-04
Last Update Post Date:
2021-08-12
Last Update Post Date Type:
ACTUAL